1.
Barro C, Affonso AAM, Waquar A, Aragao N, Bakheet A, Cajiao K, Souza ABC, Díaz LAQ, Fowler CM, Herrera R, Huapaya LAN, Kornienko K, Magalhães AMV, Menezes T d. O, Mordojovich M-A, Nosé R, Pan H, Persivale KS, Poveda C, Ramos C, Rodrigues MA, Ruiz JMV, Soares R, DangHan X. The INCA trial: a multicenter, randomized, phase II, open-label clinical trial to evaluate the combination therapy with Ipilimumab plus Nivolumab versus Chemotherapy (Pemetrexate-Cisplatin) in patients with Advanced non-squamous NSCLC naive to treatment. PPCR [Internet]. 2018Jul.25 [cited 2020Aug.14];4(1):6-13. Available from: https://journal.ppcr.org/index.php/ppcrjournal/article/view/62